Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

341 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-spasticity agents for multiple sclerosis.
Shakespeare DT, Boggild M, Young C. Shakespeare DT, et al. Cochrane Database Syst Rev. 2001;(4):CD001332. doi: 10.1002/14651858.CD001332. Cochrane Database Syst Rev. 2001. PMID: 11687107 Updated. Review.
Anti-spasticity agents for multiple sclerosis.
Shakespeare DT, Boggild M, Young C. Shakespeare DT, et al. Cochrane Database Syst Rev. 2003;(4):CD001332. doi: 10.1002/14651858.CD001332. Cochrane Database Syst Rev. 2003. PMID: 14583932 Review.
Anticholinergics for urinary symptoms in multiple sclerosis.
Nicholas RS, Friede T, Hollis S, Young CA. Nicholas RS, et al. Among authors: young ca. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004193. doi: 10.1002/14651858.CD004193.pub2. Cochrane Database Syst Rev. 2009. PMID: 19160231 Updated. Review.
Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31].
Al-Chalabi A, Shaw PJ, Young CA, Morrison KE, Murphy C, Thornhill M, Kelly J, Steen IN, Leigh PN; UKMND-LiCALS. Al-Chalabi A, et al. Among authors: young ca. BMC Neurol. 2011 Sep 21;11:111. doi: 10.1186/1471-2377-11-111. BMC Neurol. 2011. PMID: 21936930 Free PMC article. Clinical Trial.
Management of sialorrhoea in motor neuron disease: a survey of current UK practice.
Hobson EV, McGeachan A, Al-Chalabi A, Chandran S, Crawley F, Dick D, Donaghy C, Ealing J, Ellis CM, Gorrie G, Hanemann CO, Harrower T, Jung A, Majeed T, Malaspina A, Morrison K, Orrell RW, Pall H, Pinto A, Talbot K, Turner MR, Williams TL, Young CA, Shaw PJ, McDermott CJ. Hobson EV, et al. Among authors: young ca. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Dec;14(7-8):521-7. doi: 10.3109/21678421.2013.790452. Epub 2013 May 7. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23647474
Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.
Balendra R, Jones A, Jivraj N, Steen IN, Young CA, Shaw PJ, Turner MR, Leigh PN, Al-Chalabi A; UK-MND LiCALS Study Group, Mito Target ALS Study Group. Balendra R, et al. Among authors: young ca. J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):45-9. doi: 10.1136/jnnp-2013-306865. Epub 2014 Jan 24. J Neurol Neurosurg Psychiatry. 2015. PMID: 24463480 Free article.
Regionality of disease progression predicts prognosis in amyotrophic lateral sclerosis.
van der Kleij LA, Jones AR, Steen IN, Young CA, Shaw PJ, Shaw CE, Leigh PN, Turner MR, Al-Chalabi A. van der Kleij LA, et al. Among authors: young ca. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):442-7. doi: 10.3109/21678421.2015.1051987. Epub 2015 Jun 17. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 26083873
A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosis.
Shefner JM, Wolff AA, Meng L, Bian A, Lee J, Barragan D, Andrews JA; BENEFIT-ALS Study Group. Shefner JM, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2016 Jul-Aug;17(5-6):426-435. doi: 10.3109/21678421.2016.1148169. Epub 2016 Mar 16. Amyotroph Lateral Scler Frontotemporal Degener. 2016. PMID: 26982815 Clinical Trial.
A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosis.
McGeachan AJ, Hobson EV, Al-Chalabi A, Stephenson J, Chandran S, Crawley F, Dick D, Donaghy C, Ellis CM, Gorrie G, Hanemann CO, Harrower T, Jung A, Malaspina A, Morrison KE, Orrell RW, Talbot K, Turner MR, Williams TL, Young CA, Shaw PJ, McDermott CJ. McGeachan AJ, et al. Among authors: young ca. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):1-9. doi: 10.1080/21678421.2016.1221433. Epub 2016 Aug 31. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 27579520 Free article.
341 results